| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 7e-05 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |